Fate (FATE)
Develops off-the-shelf iPSC-derived CAR T and CAR NK therapies for autoimmune disease and cancer.
$2.46
vs last close−0.13 (−4.84%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 60.14% | 72.06M shares | |
|---|---|---|---|
| 162 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 5.54% | 6.63M shares | |
| 7 holders · as of Aug 5, 2026 | |||
| Strategic holders | 7.49% | 8.98M shares | |
| 1 holder · as of Jul 3, 2025 | |||
| Other | ≈ 26.83% | 32.15M shares | |
| remainder | |||
119.82M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
162 holders · 72.06M shares · 33 new positions · 88 increased · 38 reduced · 33 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Redmile Group, LLC | 12.87M | 10.74% | 0 | Aug 14, 2026 |
| BlackRock, Inc. | 7.30M | 6.09% | −2.77M | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 4.55M | 3.79% | +411.3K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 4.45M | 3.71% | +253.5K | Aug 13, 2026 |
| Acadian Asset Management LLC | 4.35M | 3.63% | +231.1K | Aug 13, 2026 |
| AQR Capital Management LLC | 3.84M | 3.20% | +835.7K | Aug 14, 2026 |
| Two Sigma Investments, LP | 3.59M | 3.00% | +123.1K | Aug 14, 2026 |
| Johnson & Johnson | 3.38M | 2.82% | 0 | Aug 6, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Redmile Group, LLCincl. RedCo II Master Fund, L.P., Jeremy C. Green +1 more | 14.90% | 18.23M | 13D | Apr 22, 2026 |
| BlackRock, Inc. | 6.90% | 7.85M | 13G | Apr 23, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 4, 2026 | Bahram Valamehrdirector, officer: President and CEO | Sale | 43,947 | $2.46 | 591,815 |
| Aug 4, 2026 | Cindy Tahlofficer: See Remarks | Sale | 38,800 | $2.46 | 589,355 |
| May 20, 2026 | Bahram Valamehrdirector, officer: President and CEO | Sale | 28,946 | $1.88 | 635,762 |
| May 20, 2026 | Cindy Tahlofficer: See Remarks | Sale | 25,590 | $1.88 | 628,155 |
| Jan 9, 2026 | Bahram Valamehrdirector, officer: President and CEO | Sale | 5,190 | $1.07 | 329,708 |
| Jan 9, 2026 | Cindy Tahlofficer: See Remarks | Sale | 10,589 | $1.06 | 387,081 |
House and Senate disclosures
Not reported.